研究单位:[1]Beijing TongRen Hospital,Beijing,China[2]Anhui Palo Alto Pharmaceuticals, Inc.
研究目的:
PA9159 is a highly potent novel corticosteroid. The purpose of this study is to exam the safety, tolerability, and pharmacokinetics of single and repeat dosing of intranasal PA9159, to establish maximum tolerated dose in healthy chinese adult